Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Innocenti

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.
NAR Genomics and Bioinformatics|June 30, 2025
Novel treatment-specific causal biomarkers for colorectal cancer by omics integrationAkram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.
Personalized Medicine|May 17, 2018
Bridging genomics research between developed and developing countries: the Genomic Medicine AllianceDavid N Cooper, Angela Brand, Vita Dolzan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell linesWanqing Liu, Xiaolin Wu, Wei Zhang, et al.
Leukemia & Lymphoma|October 6, 2010
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasePeter H O'Donnell, Andrew S Artz, Samir D Undevia, et al.
American Journal of Human Genetics|August 22, 2024
Liver eQTL meta-analysis illuminates potential molecular mechanisms of cardiometabolic traitsK Alaine Broadaway, Sarah M Brotman, Jonathan D Rosen, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-<i>β</i>2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Germline <i>cis</i> variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (<i>DPYD</i>)Ting Zhang, Alisa Ambrodji, Huixing Huang, et al.
Cancer|August 10, 2021
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931)Rebecca A Snyder, Jun He, Jennifer Le-Rademacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405Francesca Battaglin, Fang-Shu Ou, Xueping Qu, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.
NAR Genomics and Bioinformatics|June 30, 2025
Novel treatment-specific causal biomarkers for colorectal cancer by omics integrationAkram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.
Personalized Medicine|May 17, 2018
Bridging genomics research between developed and developing countries: the Genomic Medicine AllianceDavid N Cooper, Angela Brand, Vita Dolzan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell linesWanqing Liu, Xiaolin Wu, Wei Zhang, et al.
Leukemia & Lymphoma|October 6, 2010
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasePeter H O'Donnell, Andrew S Artz, Samir D Undevia, et al.
American Journal of Human Genetics|August 22, 2024
Liver eQTL meta-analysis illuminates potential molecular mechanisms of cardiometabolic traitsK Alaine Broadaway, Sarah M Brotman, Jonathan D Rosen, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-<i>β</i>2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Germline <i>cis</i> variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (<i>DPYD</i>)Ting Zhang, Alisa Ambrodji, Huixing Huang, et al.
Cancer|August 10, 2021
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931)Rebecca A Snyder, Jun He, Jennifer Le-Rademacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405Francesca Battaglin, Fang-Shu Ou, Xueping Qu, et al.
Pageof 19